Literature DB >> 30773249

Cardiovascular Events and Hospital Deaths Among Patients With Severe Sepsis.

Nirav Patel1, Navkaranbir S Bajaj2, Rajkumar Doshi3, Ankur Gupta4, Rajat Kalra5, Amitoj Singh4, Lorenzo Berra6, Garima Arora1, Sumanth D Prabhu2, Pankaj Arora7.   

Abstract

The burden of cardiovascular events among patients hospitalized with severe sepsis and the association of these events with in-hospital mortality is not well known. We examined the incidence of cardiovascular events and their association with in-hospital mortality among patients with severe sepsis. Patients with severe sepsis from the New York State Inpatient Database from 2012 through 2014 were identified using a validated International Classification of Diseases 9th Revision, Clinical Modification code 995.92. The primary outcome was the incidence of cardiovascular events during the hospitalizations, defined as a composite of ischemic, acute heart failure, or arrhythmic events and the secondary outcome was in-hospital mortality. Multivariable logistic regression models were used to compare the risk of in-hospital mortality among severe sepsis patients with and without cardiovascular events. A total of 117,418 patients (mean age, 70.8 years; 50.4% males, 59.5% whites) with severe sepsis occurred during the study period 2012 to 2014. New-onset (incident) cardiovascular event occurred in 13.1%, ischemic events in 4.5%, acute heart failure events in 2.3%, and arrhythmic events in 8.0% of patients, respectively. An estimated 32.9% of patients with severe sepsis died during their hospitalization. Severe sepsis patients with new-onset cardiovascular events were associated with 30% higher odds for in-hospital mortality (odds ratio: 1.30; 95% CI: 1.23 to 1.37, p < 0.001) as compared with patients without cardiovascular events in multivariable adjusted model. In conclusion, among patients with severe sepsis, incident cardiovascular events occur frequently. Further research is required to improve recognition and treatment of new-onset cardiovascular events in patients with severe sepsis.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30773249      PMCID: PMC6455964          DOI: 10.1016/j.amjcard.2019.01.038

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  27 in total

1.  Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury.

Authors:  Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; David Schoenfeld; Herbert P Wiedemann; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin
Journal:  N Engl J Med       Date:  2006-05-21       Impact factor: 91.245

2.  Occurrence and outcomes of sepsis: influence of race.

Authors:  Viktor Y Dombrovskiy; Andrew A Martin; Jagadeeshan Sunderram; Harold L Paz
Journal:  Crit Care Med       Date:  2007-03       Impact factor: 7.598

3.  Post-Acute Care Use and Hospital Readmission after Sepsis.

Authors:  Tiffanie K Jones; Barry D Fuchs; Dylan S Small; Scott D Halpern; Asaf Hanish; Craig A Umscheid; Charles A Baillie; Meeta Prasad Kerlin; David F Gaieski; Mark E Mikkelsen
Journal:  Ann Am Thorac Soc       Date:  2015-06

Review 4.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

5.  Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis.

Authors:  Allan J Walkey; Renda Soylemez Wiener; Joanna M Ghobrial; Lesley H Curtis; Emelia J Benjamin
Journal:  JAMA       Date:  2011-11-13       Impact factor: 56.272

6.  Platelet activation is associated with myocardial infarction in patients with pneumonia.

Authors:  Roberto Cangemi; Marco Casciaro; Elisabetta Rossi; Camilla Calvieri; Tommaso Bucci; Cinzia Myriam Calabrese; Gloria Taliani; Marco Falcone; Paolo Palange; Giuliano Bertazzoni; Alessio Farcomeni; Stefania Grieco; Pasquale Pignatelli; Francesco Violi
Journal:  J Am Coll Cardiol       Date:  2014-10-27       Impact factor: 24.094

7.  Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease.

Authors:  Vicente F Corrales-Medina; Karina N Alvarez; Lisa A Weissfeld; Derek C Angus; Julio A Chirinos; Chung-Chou H Chang; Anne Newman; Laura Loehr; Aaron R Folsom; Mitchell S Elkind; Mary F Lyles; Richard A Kronmal; Sachin Yende
Journal:  JAMA       Date:  2015-01-20       Impact factor: 56.272

8.  Acute myocardial infarction in hospitalized patients with community-acquired pneumonia.

Authors:  Julio Ramirez; Stefano Aliberti; Mehdi Mirsaeidi; Paula Peyrani; Giovanni Filardo; Asad Amir; Bryan Moffett; Josh Gordon; Francesco Blasi; Jose Bordon
Journal:  Clin Infect Dis       Date:  2008-07-15       Impact factor: 9.079

9.  Risk of Acute Coronary Heart Disease After Sepsis Hospitalization in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort.

Authors:  Henry E Wang; Justin X Moore; John P Donnelly; Emily B Levitan; Monika M Safford
Journal:  Clin Infect Dis       Date:  2017-07-01       Impact factor: 9.079

Review 10.  Sepsis-induced myocardial dysfunction: pathophysiology and management.

Authors:  Yasuyuki Kakihana; Takashi Ito; Mayumi Nakahara; Keiji Yamaguchi; Tomotsugu Yasuda
Journal:  J Intensive Care       Date:  2016-03-23
View more
  3 in total

1.  Implications of Atrial Fibrillation Among Patients With Atherosclerotic Cardiovascular Disease Undergoing Noncardiac Surgery.

Authors:  Rajat Kalra; Vibhu Parcha; Nirav Patel; Anirudh Bhargava; Peng Li; Garima Arora; Pankaj Arora
Journal:  Am J Cardiol       Date:  2020-04-12       Impact factor: 2.778

Review 2.  Organ Dysfunction in Sepsis: An Ominous Trajectory From Infection To Death.

Authors:  César Caraballo; Fabián Jaimes
Journal:  Yale J Biol Med       Date:  2019-12-20

3.  Inhibition of CPT2 exacerbates cardiac dysfunction and inflammation in experimental endotoxaemia.

Authors:  Marina Makrecka-Kuka; Stanislava Korzh; Melita Videja; Reinis Vilskersts; Eduards Sevostjanovs; Olga Zharkova-Malkova; Pavel Arsenyan; Janis Kuka; Maija Dambrova; Edgars Liepinsh
Journal:  J Cell Mol Med       Date:  2020-09-07       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.